Exaire E

Language: Spanish
References: 16
Page: 42-45
PDF size: 66.70 Kb.

Text Extraction

No abstract

REFERENCES

1. Whelton A, Watson J. Nonsteroidal anti-inflammatory drugs; effects on kidney function. In: De Broe ME, Porter GA, Bennett WM, Verpooten GA, eds. Clinical Nephrotoxins: Renal Injury from Drugs and Chemicals. Dordrecht, Netherlands: Kluwer Academic Publishers, 1997; 209-22.

2. Whelton A, Hamilton CW. Nonsteroidal antiinflammatory drugs: effects on kidney function. J Clin Pharmacol 1991; 31: 588-98.

3. Whelton A, Stout RL, Spilman PS, Klasson DL. Renal effects of iburpofen, piroxicam, and sulindac in patients with asymptomatic renal failure: a prospective, randomized, crossover comparison. Ann Intern Med 1990; 112: 568-76.

4. Palmer J. Invest Med 1995; 43: 516-33.

5. Whelton A. Nephrotoxicity of nonsteroidal anti-inflammatory drugs; physiologic foundations and clinical implications. Am J Medicine 1999; 106 (Suppl 5B): S13-S24.

6. Heerdink ER, Leufkens HG, Herings RM et al. NSAIDs associated with increased risk of congestive heart failure in elderly patients taking diuretics. Arch Intern Med 1998; 283: 1108-12.

7. Houston MC. Nonsteroidal anti-inflammatory drugs and antihypertensives. Am J Med 1991; 90: 42S- 47S.

8. Pope JE, Anderson JJ, Felson DT. A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure. Arch Intern Med 1993; 153: 477-84.

9. Brater DC, Anderson S, Baird B, Campbell WB. Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men. Kidney Int 1985; 27; 66-73.

10. Brater DC. Effects of nonsteroidal anti-inflammatory drugs on renal function: focus on cyclooxygenase-2 -selective inhibition. Am J Med 1999; 107: 65S-70S.

11. Johnson AG, Nguyen RV, Day G. Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis. Ann Intern Med 1994; 121: 289-300.

12. De Leeuw PW. Nonsteroidal anti-inflammatory drugs and hypertension. The risks in perspective. Drugs 1996; 51: l79-87.

13. Whelton A, Maurath CJ, Verburg KM et al. Renal safety and tolerability of celecoxib, a novel cyclooxygenase-2 inhibitor. Am J Ther 2000; 7: 159-76.

14. Whelton A, Schulman G, Wallmarck C et al. Effects of celecoxib and naproxen on renal function in the elderly. Arch Intern Med 2000; 160: 1465-70.

15. Kahn KN, Venturini CM, Bunch RT et al. Interspecies differences in renal localization of cyclooxygenase isoforms: implication in nonsteroidal anti-inflammatory drug-related nephrotoxicity. Toxicol Pathol 1998; 26: 612-20.

16. Silverstein FE, Faich G, Goldstein JL et al. Gastrointestinal toxicity with celecoxib vs nonsteroidal antiinflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study, a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 2000; 284: 1247-55.